Tirzepatide and metabolic dysfunction-associated steatotic liver disease (MASLD) in obesity: a real-world multicenter study - Top-Institutions - MDSpire

Tirzepatide and metabolic dysfunction-associated steatotic liver disease (MASLD) in obesity: a real-world multicenter study

  • By

  • Martina Galasso

  • Ludovica Verde

  • Renato Patrone

  • Giovanni Ragozzino

  • Giuseppe Annunziata

  • Annamaria Colao

  • Luigi Barrea

  • Giovanna Muscogiuri

  • July 6, 2026

  • 0 min

Share

Top Institutions in Gastroenterology

Brief introduction explaining scope and methodology.

  • #1

    University of California, San Diego
    University of California, San Diego

    La Jolla, California

    Key Differentiators

    • Gastroenterology
    • Hepatology

  • #2

    Virginia Commonwealth University
    Virginia Commonwealth University

    Richmond, Virginia

    Key Differentiators

    • Gastroenterology
    • Hepatology

Original Source(s)

Tirzepatide and metabolic dysfunction-associated steatotic liver disease (MASLD) in obesity: a real-world multicenter study

  • by Martina Galasso, Ludovica Verde, Renato Patrone, Giovanni Ragozzino, Giuseppe Annunziata, Annamaria Colao, Luigi Barrea, Giovanna Muscogiuri

  • July 6, 2026

Related Content

Association of preoperative CT-derived visceral adipose tissue index with synchronous metastasis and metastasis-free survival after curative-intent surgery in colorectal cancer

Giant paraumbilical hernia causing gastric outlet obstruction in a young man with class III obesity: a case report and literature review

Correction: Development of an optimal pathway for endoscopic sleeve gastroplasty implementation in the NHS: a modified nominal group technique study